Corona Updates

Indian Immunologicals hands over first lot of Covaxin drug substance to Bharat Biotech

Hyderabad (Telangana) [India]: In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at the earliest, the Central Government requested that Indian Immunologicals Limited (IIL) and Bharat Biotech International Limited (BBIL) to join hands in April 2021.IIL in a short period of time has performed several activities including the signing of four agreements with BBIL, repurposing its manufacturing facility in Hyderabad, procurement of key raw materials and consumables, procurement of key equipment for the process, technology transfer, trials at Research and Development scale, training etc. These activities were all done at breakneck speed and production commenced in July 2021. The batches so produced at IIL’s manufacturing facility have been tested at BBIL and IIL and meets the quality specifications for the drug substance. The yields are more than expected.In a simple…

City News Hyderabad

Hyderabad-based Indian Immunological Limited to produce 10-15 million vaccine doses monthly

In order to ramp up vaccine production as the country battles the second wave of coronavirus, the Centre has decided to support some PSU companies with grants under ‘Mission COVID Suraksha’. Under this move, one such company is Hyderabad-based Indian Immunological Limited (IIL), which is expected to produce nearly 10-15 million vaccine doses monthly. Meanwhile, the Ministry of Health and Family Welfare said that more than 22.46 crore vaccine doses have been provided to the states and union territories, and 1.84 crore doses are still available with the states/UTs to be administered while 3,20,380 vaccine doses are in the pipeline and will be received by the states/UTs within the next few days.